BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 8895367)

  • 21. The association between integrin-associated protein and SHPS-1 regulates insulin-like growth factor-I receptor signaling in vascular smooth muscle cells.
    Maile LA; Badley-Clarke J; Clemmons DR
    Mol Biol Cell; 2003 Sep; 14(9):3519-28. PubMed ID: 12972543
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neoplastic transformation induced by insulin receptor substrate-1 overexpression requires an interaction with both Grb2 and Syp signaling molecules.
    Tanaka S; Ito T; Wands JR
    J Biol Chem; 1996 Jun; 271(24):14610-6. PubMed ID: 8662827
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phosphatidylinositol 3'-kinase associates with an insulin receptor substrate-1 serine kinase distinct from its intrinsic serine kinase.
    Cengel KA; Kason RE; Freund GG
    Biochem J; 1998 Oct; 335 ( Pt 2)(Pt 2):397-404. PubMed ID: 9761740
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insulin-like growth factor-1 (IGF-1) receptor-insulin receptor substrate complexes in the uterus. Altered signaling response to estradiol in the IGF-1(m/m) mouse.
    Richards RG; Walker MP; Sebastian J; DiAugustine RP
    J Biol Chem; 1998 May; 273(19):11962-9. PubMed ID: 9565625
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Roles of the complex formation of SHPS-1 with SHP-2 in insulin-stimulated mitogen-activated protein kinase activation.
    Takada T; Matozaki T; Takeda H; Fukunaga K; Noguchi T; Fujioka Y; Okazaki I; Tsuda M; Yamao T; Ochi F; Kasuga M
    J Biol Chem; 1998 Apr; 273(15):9234-42. PubMed ID: 9535915
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multiple in vivo phosphorylated tyrosine phosphatase SHP-2 engages binding to Grb2 via tyrosine 584.
    Vogel W; Ullrich A
    Cell Growth Differ; 1996 Dec; 7(12):1589-97. PubMed ID: 8959326
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tyrosine residues in the C-terminal domain of the insulin-like growth factor-I receptor mediate mitogenic and tumorigenic signals.
    Esposito DL; Blakesley VA; Koval AP; Scrimgeour AG; LeRoith D
    Endocrinology; 1997 Jul; 138(7):2979-88. PubMed ID: 9202243
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tyrosine 1213 of Flt-1 is a major binding site of Nck and SHP-2.
    Igarashi K; Isohara T; Kato T; Shigeta K; Yamano T; Uno I
    Biochem Biophys Res Commun; 1998 May; 246(1):95-9. PubMed ID: 9600074
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interaction between insulin-like growth factor-I receptor and alphaVbeta3 integrin linked signaling pathways: cellular responses to changes in multiple signaling inputs.
    Clemmons DR; Maile LA
    Mol Endocrinol; 2005 Jan; 19(1):1-11. PubMed ID: 15528274
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The tyrosine phosphatase SHP-2 is required for mediating phosphatidylinositol 3-kinase/Akt activation by growth factors.
    Wu CJ; O'Rourke DM; Feng GS; Johnson GR; Wang Q; Greene MI
    Oncogene; 2001 Sep; 20(42):6018-25. PubMed ID: 11593409
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Site-directed mutagenesis and yeast two-hybrid studies of the insulin and insulin-like growth factor-1 receptors: the Src homology-2 domain-containing protein hGrb10 binds to the autophosphorylated tyrosine residues in the kinase domain of the insulin receptor.
    Dong LQ; Farris S; Christal J; Liu F
    Mol Endocrinol; 1997 Nov; 11(12):1757-65. PubMed ID: 9369444
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The COOH-terminal tyrosine phosphorylation sites on IRS-1 bind SHP-2 and negatively regulate insulin signaling.
    Myers MG; Mendez R; Shi P; Pierce JH; Rhoads R; White MF
    J Biol Chem; 1998 Oct; 273(41):26908-14. PubMed ID: 9756938
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A yeast two-hybrid study of human p97/Gab2 interactions with its SH2 domain-containing binding partners.
    Crouin C; Arnaud M; Gesbert F; Camonis J; Bertoglio J
    FEBS Lett; 2001 Apr; 495(3):148-53. PubMed ID: 11334882
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunoreceptor tyrosine-based inhibitory motif of the IL-4 receptor associates with SH2-containing phosphatases and regulates IL-4-induced proliferation.
    Kashiwada M; Giallourakis CC; Pan PY; Rothman PB
    J Immunol; 2001 Dec; 167(11):6382-7. PubMed ID: 11714803
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SH2-Containing protein tyrosine phosphatase-1 (SHP-1) association with Jak2 in UT-7/Epo cells.
    Wu DW; Stark KC; Dunnington D; Dillon SB; Yi T; Jones C; Pelus LM
    Blood Cells Mol Dis; 2000 Feb; 26(1):15-24. PubMed ID: 10772872
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tyrosine dephosphorylation and deactivation of insulin receptor substrate-1 by protein-tyrosine phosphatase 1B. Possible facilitation by the formation of a ternary complex with the Grb2 adaptor protein.
    Goldstein BJ; Bittner-Kowalczyk A; White MF; Harbeck M
    J Biol Chem; 2000 Feb; 275(6):4283-9. PubMed ID: 10660596
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structural and functional characterization of insulin receptor substrate proteins and the molecular mechanisms of their interaction with insulin superfamily tyrosine kinase receptors and effector proteins.
    Shpakov AO; Pertseva MN
    Membr Cell Biol; 2000; 13(4):455-84. PubMed ID: 10926366
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence for a differential interaction of SHC and the insulin receptor substrate-1 (IRS-1) with the insulin-like growth factor-I (IGF-I) receptor in the yeast two-hybrid system.
    Tartare-Deckert S; Sawka-Verhelle D; Murdaca J; Van Obberghen E
    J Biol Chem; 1995 Oct; 270(40):23456-60. PubMed ID: 7559507
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of insulin-like growth factor I receptor dephosphorylation by SHPS-1 and the tyrosine phosphatase SHP-2.
    Maile LA; Clemmons DR
    J Biol Chem; 2002 Mar; 277(11):8955-60. PubMed ID: 11779860
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Both SH2 domains are involved in interaction of SHP-1 with the epidermal growth factor receptor but cannot confer receptor-directed activity to SHP-1/SHP-2 chimera.
    Tenev T; Keilhack H; Tomic S; Stoyanov B; Stein-Gerlach M; Lammers R; Krivtsov AV; Ullrich A; Böhmer FD
    J Biol Chem; 1997 Feb; 272(9):5966-73. PubMed ID: 9038217
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.